Company
A new era for human health
Welcome to our Canadian website. GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
A signal for change
1:48
Our strategy
We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
$3 mil +
contributed over the last 20 years to support the hospice palliative care movement in Canada
GSK Global links
Visit our Global site for additional features
Press releases
- In honour of World COPD Day GSK promotes environmentally responsible disposal of used inhalers through health product stewardship program
- Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia
- Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
Choose your path
By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.
